Dr. Matthew Weir, MD
Claim this profileVictoria Hospital
Studies Kidney Disease
Studies Chronic Kidney Failure
4 reported clinical trials
6 drugs studied
Affiliated Hospitals
Clinical Trials Matthew Weir, MD is currently running
Phosphate Level Management
for Kidney Failure
During end-stage kidney disease, clinical guidelines suggest reducing elevated phosphate levels in the blood. However, the effect of lowering blood phosphate levels on important patient-centred outcomes has never been tested. This trial will evaluate whether compared to high levels, lowering blood phosphate levels would reduce death or major events due to heart disease, improve physical health, and be cost-effective.
Recruiting1 award N/A4 criteria
Spironolactone
for Kidney Failure
This trial tests if spironolactone, a pill that blocks a harmful hormone, can reduce heart problems in dialysis patients. These patients are at high risk of heart failure and death, and the pill aims to lower blood pressure and protect their hearts. Spironolactone has been shown to effectively lower blood pressure in patients with resistant hypertension.
Recruiting3 awards Phase 34 criteria
More about Matthew Weir, MD
Clinical Trial Related4 years of experience running clinical trials · Led 4 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Matthew Weir, MD has experience with
- Spironolactone
- Placebo Oral Tablet
- Clazakizumab
- Multimodal Intervention
- Liberal Phosphate Target
- Intensive Phosphate Target
Breakdown of trials Matthew Weir, MD has run
Chronic Kidney Failure
Antibody Mediated Rejection
Acute Kidney Injury
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Matthew Weir, MD specialize in?
Matthew Weir, MD focuses on Kidney Disease and Chronic Kidney Failure. In particular, much of their work with Kidney Disease has involved treating patients, or patients who are undergoing treatment.
Is Matthew Weir, MD currently recruiting for clinical trials?
Yes, Matthew Weir, MD is currently recruiting for 3 clinical trials in London Ontario. If you're interested in participating, you should apply.
Are there any treatments that Matthew Weir, MD has studied deeply?
Yes, Matthew Weir, MD has studied treatments such as Spironolactone, Placebo Oral Tablet, Clazakizumab.
What is the best way to schedule an appointment with Matthew Weir, MD?
Apply for one of the trials that Matthew Weir, MD is conducting.
What is the office address of Matthew Weir, MD?
The office of Matthew Weir, MD is located at: Victoria Hospital, London, Ontario N6A 5W9 Canada. This is the address for their practice at the Victoria Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.